Gainers

Shares of Apple Inc. (NASDAQ:AAPL) rose in pre-market trading as the company posted stronger-than-expected third-quarter results. The iPhone maker reported fiscal third-quarter revenue of $94 billion, beating analyst estimates of $89.04 billion by 5.6%. Earnings per share came in at $1.57,...

Shares of Meta Platforms, Inc. (NASDAQ:META) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above estimates. Meta reported second-quarter revenue of $47.52 billion, beating analyst estimates...

Shares of LendingClub Corporation (NYSE:LC) rose sharply in pre-market trading after the company reported better-than-expected second-quarter sales results. LendingClub reported a strong second-quarter performance, with a 156% increase in net income. The company's second-quarter revenue and net...

Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results, raised its FY25 guidance, and issued third-quarter guidance above estimates. Celestica reported quarterly earnings of $1.39 per share which beat...

Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised its full-year guidance. Medpace expects 2025 revenue to be in the range of $2.42 billion to $2.52 billion, up from prior guidance...

Shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) rose sharply in pre-market trading after the company posted better-than-expected second-quarter results after Thursday's closing bell. Interactive Brokers reported quarterly earnings of 51 cents per share, which beat the analyst consensus...

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in pre-market trading after the company announced it will engage in strategic restructuring and cost savings. After the market close on Wednesday, Sarepta Therapeutics introduced a strategic restructuring plan that involves focusing on...

Shares of Datavault AI Inc. (NASDAQ:DVLT) rose sharply in today's pre-market trading after the company entered into a licensing deal with IBM for program subscriptions. Datavault AI shares jumped 7.1% to $0.7598 in the pre-market trading session. Here are some other stocks moving in pre-market...

Shares of Levi Strauss & Co. (NYSE:LEVI) rose sharply in today's pre-market trading as the company reported stronger-than-expected second-quarter financial results and raised its full-year guidance. The company reported second-quarter revenue of $1.45 billion, beating analyst estimates of $1.37...

Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) rose sharply in today's pre-market trading after the company disclosed positive 16-week data from Phase 2 APEX clinical trial of APG777, its potentially best-in-class anti-IL-13 antibody, in moderate-to-severe atopic dermatitis. Apogee Therapeutics...

Shares of Datadog Inc (NASDAQ:DDOG) rose sharply in pre-market trading followed the company's announcement of its inclusion in the S&P 500 index. S&P Dow Jones announced on July 2, 2025, Datadog is set to join the S&P 500.Datadog will officially replace Juniper Networks (NYSE:JNPR),...

Shares of Venus Concept Inc. (NASDAQ:VERO) rose sharply in today's pre-market trading after Madryn Asset Management increased its stake in the company to 85.5%. Venus Concept shares jumped 32.5% to $2.91 in the pre-market trading session. Here are some other stocks moving in pre-market trading....

Shares of Worthington Steel, Inc. (NYSE:WS) rose sharply in today's pre-market trading as the company reported stronger-than-expected financial results for the fourth quarter. The company reported quarterly earnings of $1.05 per share, which beat the analyst consensus estimate of 82 cents per share...

Shares of BlackBerry Limited (NYSE:BB) rose sharply in today's pre-market trading following first-quarter results. BlackBerry reported quarterly earnings of two cents per share, which beat the analyst consensus estimate of zero cents. Quarterly revenue of $121.7 million beat the Street estimate of...

Shares of Nektar Therapeutics (NASDAQ:NKTR) rose sharply in today's pre-market trading after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025. Nektar...